Article Versions Notes

Nani P, Ladopoulou M, Papaioannou EH, Papagianni ED, Antonatos C, Xiropotamos P, Kapsoritakis A, Potamianos PS, Karmiris K, Tzathas C, et al. Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and Psoriasis. Genes. 2023; 14(2):445. https://doi.org/10.3390/genes14020445

Nani, Paraskevi, Melpomeni Ladopoulou, Evgenia H. Papaioannou, Evangelia D. Papagianni, Charalabos Antonatos, Panagiotis Xiropotamos, Andreas Kapsoritakis, Petros S. Potamianos, Konstantinos Karmiris, Charalambos Tzathas, and et al. 2023. "Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and Psoriasis" Genes 14, no. 2: 445. https://doi.org/10.3390/genes14020445

Nani, P., Ladopoulou, M., Papaioannou, E. H., Papagianni, E. D., Antonatos, C., Xiropotamos, P., Kapsoritakis, A., Potamianos, P. S., Karmiris, K., Tzathas, C., Patsatsi, A., Lazaridou, E., Zafiriou, E., Roussaki-Schulze, A., Georgiou, S., Grafanaki, K., Georgakilas, G. K., & Vasilopoulos, Y. (2023). Pharmacogenetic Analysis of the MIR146A rs2910164 and MIR155 rs767649 Polymorphisms and Response to Anti-TNF Treatment in Patients with Crohn’s Disease and Psoriasis. Genes, 14(2), 445. https://doi.org/10.3390/genes14020445